• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妇产科经济学评价研究的方法学质量:系统评价。

The methodological quality of economic evaluation studies in obstetrics and gynecology: a systematic review.

机构信息

Department of Obstetrics and Gynecology, Academic Medical Centre, Amsterdam, The Netherlands.

出版信息

Am J Perinatol. 2013 Apr;30(4):253-60. doi: 10.1055/s-0032-1323591. Epub 2012 Aug 23.

DOI:10.1055/s-0032-1323591
PMID:22918680
Abstract

We evaluated the methodological quality of economic evaluation studies in the field of obstetrics and gynecology published in the last decade. A MEDLINE search was performed to find economic evaluation studies in obstetrics and gynecology from the years 1997 through 2009. We included full economic evaluation studies concerning tests or interventions in the field of obstetrics or gynecology. Each included study was evaluated by two reviewers using a quality checklist that was based on international guidelines for medical economic evaluation studies and a checklist used in a previous review. The mean number of quality criteria adhered to was 23 of 30 items, whereas five articles (3%) met all 30 criteria. Compliance was low for the description of the perspective (40%), the completeness of costs looking at the perspective (48%) or time horizon (48%), and reporting of quantities of resources (47%). Furthermore, if no discounting was applied, an explanation was infrequently given (14%). A comparison of study quality to that reported by Smith and Blackmore showed a considerable improvement in the following criteria: presentation perspective (from 19 to 40%), statement of primary outcome measure (from 72 to 81%), completeness costs looking at the time horizon (from 14 to 48%), the presentation of discount rates (from 10 to 54%), details of sensitivity analyses (from 21 to 61%), reporting incremental results (from 17 to 70%), and reporting a summary measure (from 57 to 74%). The quality of economic studies in obstetrics and gynecology has considerably improved in the last decade, but room for further improvement is present.

摘要

我们评估了过去十年中发表的妇产科领域经济评估研究的方法学质量。通过 MEDLINE 搜索,我们找到了 1997 年至 2009 年期间妇产科的经济评估研究。我们纳入了关于妇产科测试或干预的完整经济评估研究。每篇纳入的研究均由两位评审员使用基于国际医疗经济评估研究指南和之前一篇综述中使用的检查表的质量检查表进行评估。遵守的质量标准平均值为 30 项中的 23 项,而 5 篇文章(3%)符合所有 30 项标准。在描述视角(40%)、从视角(48%)或时间范围(48%)考虑成本的完整性、以及报告资源数量(47%)方面,合规性较低。此外,如果不应用折扣,则很少给出解释(14%)。将研究质量与 Smith 和 Blackmore 的报告进行比较后,以下标准有了相当大的改进:呈现视角(从 19%提高到 40%)、主要结果衡量指标的说明(从 72%提高到 81%)、从时间范围考虑成本的完整性(从 14%提高到 48%)、折现率的呈现(从 10%提高到 54%)、敏感性分析的详细信息(从 21%提高到 61%)、报告增量结果(从 17%提高到 70%)和报告综合指标(从 57%提高到 74%)。在过去十年中,妇产科经济研究的质量有了相当大的提高,但仍有进一步提高的空间。

相似文献

1
The methodological quality of economic evaluation studies in obstetrics and gynecology: a systematic review.妇产科经济学评价研究的方法学质量:系统评价。
Am J Perinatol. 2013 Apr;30(4):253-60. doi: 10.1055/s-0032-1323591. Epub 2012 Aug 23.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
3
Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.试验报告的统一标准(CONSORT)以及医学期刊上发表的随机对照试验(RCT)的报告完整性。
Cochrane Database Syst Rev. 2012 Nov 14;11(11):MR000030. doi: 10.1002/14651858.MR000030.pub2.
4
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.
5
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
6
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
7
The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描(FDG-PET/CT)在结直肠癌术前分期中的价值:系统评价和经济评估。
Health Technol Assess. 2011 Sep;15(35):1-192, iii-iv. doi: 10.3310/hta15350.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.噻托溴铵与长效β受体激动剂治疗稳定期慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2.
10
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.

引用本文的文献

1
Challenges in economic evaluations in obstetric care: a scoping review and expert opinion.产科护理中的经济评估挑战:范围综述和专家意见。
BJOG. 2020 Oct;127(11):1399-1407. doi: 10.1111/1471-0528.16243. Epub 2020 May 5.
2
Heterogeneity of cost estimates in health economic evaluation research. A systematic review of stress urinary incontinence studies.健康经济评估研究中成本估算的异质性:压力性尿失禁研究的系统评价
Int Urogynecol J. 2019 Jul;30(7):1045-1059. doi: 10.1007/s00192-018-3814-0. Epub 2019 Feb 4.
3
Reporting and Analysis of Trial-Based Cost-Effectiveness Evaluations in Obstetrics and Gynaecology.
基于试验的成本效益评估在妇产科中的报告和分析。
Pharmacoeconomics. 2017 Oct;35(10):1007-1033. doi: 10.1007/s40273-017-0531-3.
4
Vaccination program in a resource-limited setting: A case study in the Philippines.资源有限环境下的疫苗接种计划:菲律宾的一个案例研究
Vaccine. 2016 Sep 14;34(40):4814-9. doi: 10.1016/j.vaccine.2016.08.014. Epub 2016 Aug 13.
5
Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden.瑞典新鲜及冷冻体外受精/卵胞浆内单精子注射周期中高纯度人绝经期促性腺激素与重组人促卵泡激素的经济学评估
Clinicoecon Outcomes Res. 2013 Aug 9;5:381-97. doi: 10.2147/CEOR.S48994. eCollection 2013.